Tuesday, July 17, 2018

Roche said on Tuesday its investigational drug baloxavir marboxil reduced symptoms in people at high risk of complications from flu, a boost to the Swiss drugmaker's efforts to win approval for the single-dose, oral anti-viral medicine.


from Reuters: Health News https://ift.tt/2zMGpP8

Related Posts:

  • LATEST HEALTH NEWSAbbVie Inc said on Tuesday it signed a U.S. licensing deal with Mylan NV for its proposed biosimilar to AbbVie's blockbuster drug Humira, in a move that will give it more near-term control over the competition. from Reut… Read More
  • LATEST HEALTH NEWSUnitedHealth Group Inc, the largest U.S. health insurer, on Tuesday reported second-quarter medical costs slightly higher than Wall Street expectations, sending its shares down 4 percent and weighing on the rest of the sector… Read More
  • LATEST HEALTH NEWSJohnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its shares rose more than … Read More
  • LATEST HEALTH NEWSUnitedHealth Group Inc Chief Financial Officer John Rex said on Tuesday that patient medical costs are running within the company's expectations and forecast they will stay that way this year. from Reuters: Health News h… Read More
  • LATEST HEALTH NEWSBillionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will award $30 million over three years to encourage development of new tests for early detection of Alzheimer's disease. … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner